Literature DB >> 6705173

Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.

D G Harrison, D W Ferguson, S M Collins, D J Skorton, E E Ericksen, J M Kioschos, M L Marcus, C W White.   

Abstract

We tested the hypothesis that lesion rethrombosis after streptokinase reperfusion is related to luminal size of the residual stenosis. Two independent techniques of analyzing coronary angiograms, quantitative coronary angiography and computer-based videodensitometry, were used to estimate the size of the residual lumen immediately after discontinuation of streptokinase. These techniques were selected because they provide independent estimates of cross-sectional area of a lesion with high degrees of reproducibility and minimal observer variability. Twenty-four patients who had undergone successful reperfusion with streptokinase were studied. Seven patients had lesion rethrombosis documented either on a repeat angiogram, at autopsy, or, in one case, by the fact that the patient had an acute transmural infarction resulting in death. Vessel patency was documented by repeat coronary angiography 8 to 14 days after initial streptokinase reperfusion in the other 17 patients. As assessed by quantitative coronary angiography, seven of 13 patients (54%) with minimal luminal cross-sectional areas of less than 0.4 mm2 had rethrombosis. None of the 11 patients with lumens greater than 0.4 mm2 had rethrombosis. In the 17 patients with vessels that remained patent the size of the residual lesion at repeat catheterization was compared with its size immediately after reperfusion with streptokinase. Over the intervening 8 to 14 day interval, an average percentage increase in minimal cross-sectional area of 116 +/- 34% was observed. In seven patients minimal luminal cross-sectional area more than doubled. Integrated optical density, an index of the severity of coronary stenosis derived from computer-based videodensitometry, was also useful in identifying a subgroup of patients at high risk for rethrombosis of lesion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705173     DOI: 10.1161/01.cir.69.5.991

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  29 in total

1.  Comparison of digital and cine coronary arteriography.

Authors:  J C Gurley; S E Nissen
Journal:  Int J Card Imaging       Date:  1990

2.  Coronary angioplasty in emergency treatment of myocardial infarction in a community-hospital setting.

Authors:  R P Sotolongo; M L Smith; W S Margolis
Journal:  Tex Heart Inst J       Date:  1990

3.  Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.

Authors:  P Golino; J T Willerson
Journal:  Tex Heart Inst J       Date:  1991

Review 4.  Thromboxane synthase inhibitors and receptor antagonists.

Authors:  J Vermylen; H Deckmyn
Journal:  Cardiovasc Drugs Ther       Date:  1992-02       Impact factor: 3.727

Review 5.  Successful and unsuccessful coronary thrombolysis.

Authors:  M J Davies
Journal:  Br Heart J       Date:  1989-05

Review 6.  Thrombolytic therapy in acute myocardial infarction.

Authors:  P Oldershaw
Journal:  Postgrad Med J       Date:  1988-12       Impact factor: 2.401

7.  A microcomputer based automated, quantitative coronary angiographic analysis system.

Authors:  W P Santamore; F R Kahl; M A Kutcher; M Negin; J L Whiteman; J P Kase; W C Little
Journal:  Ann Biomed Eng       Date:  1988       Impact factor: 3.934

8.  Early remodelling of coronary stenoses after thrombolytic treatment in patients with acute myocardial infarction.

Authors:  D Tousoulis; F Andreotti; D Hackett; A W Haider; A Maseri; G Davies
Journal:  Br Heart J       Date:  1995-09

9.  Influence of the rt-PA dose (1 mg/kg versus 1.5 mg/kg) and duration of administration on the patency of infarct-related coronary arteries in 81 patients.

Authors:  P Gibelin; F Tiger; V Moles; S Bossan; P Blanc; M Baudouy; P Morand
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

10.  Assessment of Holter ST monitoring for risk stratification in patients with acute myocardial infarction treated by thrombolysis.

Authors:  R Stevenson; K Ranjadayalan; P Wilkinson; B Marchant; A D Timmis
Journal:  Br Heart J       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.